• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Aegerion Pharmaceuticals, Inc. (AEGR)

    -NasdaqGS
    7.05 Down 0.19(2.62%) Feb 5, 4:00PM EST
    Prev Close:7.24
    Open:7.18
    Bid:N/A
    Ask:8.67 x 4000
    1y Target Est:17.50
    Beta:2.08308
    Earnings Date:Feb 24 - Feb 29 (Est.)
    Day's Range:6.97 - 7.43
    52wk Range:6.20 - 28.97
    Volume:276,335
    Avg Vol (3m):792,426
    Market Cap:204.01M
    P/E (ttm):N/A
    EPS (ttm):-1.57
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AEGR

    Comparison

    Symbol% ChgMkt Cap
    AEGRDown 2.62%204.01M
    PFEUp 0.10%179.22B
    AZNDown 1.44%75.92B
    MRKUp 1.63%137.95B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):0.86
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.09
    Quarterly EPS Est (Dec-15) :-0.84
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):-0.68

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback